Oncotarget is a medical journal prepared weekly and covering a broad range of research in oncology. This journal, an Impact publication, was launched in 2010. The chief editors of the journal are Mikhail Blagosklonny and Andrei V. Gudkov.
Mikhail, a scientist, studies aging alongside cancer. He works at the Roswell Park Cancer Institute in New York as a professor of oncology. He studied at St. Petersburg where he earned both his Master’s degree and his PhD. He studied internal medicine at a master’s level and also experimental medicine on ResearchGate.net at PhD level.
In 2002, he became associate professor at New York Medical College. This position he occupied before proceeding to become a senior scientist in Albany’s Ordway Research Institute on oncotarget.com. In 2009, Mikhail joint Roswell Park Cancer Institute as a professor of oncology.
Mikhail’s research areas include cancer, anti-ageing medication and aging mechanisms: biogerontology. He is a chief editor along with Andrei V. Gudkov.
Andrei V. Gudkov
He is a cancer researcher at http://www.scimagojr.com/journalsearch.php?q=19900191708&tip=sid. He was appointed to the position of Senior VP for basic research. In the department of cell stress biology, he is the senior most person. He is also a senior individual in the National Cancer Institute (NCI). He also holds seniority in the Cancer Centre Support Grant at the Roswell Park Cancer Institute (RPCI).
Since he also holds the position of senior vice president, he is charged with the responsibility of developing strategic plans for scientific programs and enhancing collaboration with national centers of academic excellence. In the past, Dr. Gudkov served in the molecular genetics department at Case Research University where he taught biochemistry.
His experimental oncology doctoral degree was earned from USSR’s Cancer Research Centre. He has also studied molecular biology in USSR’s Moscow University. He holds about 27 patents and is an author of 135 scientific articles.
Oncotarget is a weekly multi disciplinary journal that can be accessed free. The mission of the journal is to ensure that scientific results are readily available to the public. The journal also aspires to have all discoveries shared in a flash. Indeed, the journal is all about eliminating borders between specialties. Additionally, Oncotarget also aspires to bring together specialties in biomedical science. The journal has since 2010 published 370 papers on the field of oxygen.